Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma.
Glas M, Coch C, Trageser D, Dassler J, Simon M, Koch P, Mertens J, Quandel T, Gorris R, Reinartz R, Wieland A, Von Lehe M, Pusch A, Roy K, Schlee M, Neumann H, Fimmers R, Herrlinger U, Brüstle O, Hartmann G, Besch R, Scheffler B.
Glas M, et al. Among authors: mertens j.
Stem Cells. 2013 Jun;31(6):1064-74. doi: 10.1002/stem.1350.
Stem Cells. 2013.
PMID: 23390110